But that's a nice big jumbo lobster. Hey, by the way, this price is the same as last year. And then here's another good one.Hey, Matt, this might >> Okay, that's a big tomahawk steak right now. These >> that's our ranchers come back from the Midwest. Uh uh and this is what they want is a tomahawk steak.>> And you know what. Here's a couple things that went down. Obviously, eggs are down about a dollar a dozen right now.Another thing that's down, huge amount of butters being used today and tomorrow uh in the ...

Core Viewpoint - Austrian dairy group SalzburgMilch is planning a strategic merger with local peer Pinzgau Milch, aiming to create a joint company and enhance collaboration in dairy product manufacturing [1][5]. Company Overview - SalzburgMilch is Austria's third-largest dairy group, sourcing milk from approximately 2,400 farming suppliers and marketing over 600 products. It processes 331 million kilograms of milk annually and employs around 450 people [3]. - Pinzgau Milch, a contract manufacturer of dairy products, reported a turnover of €155 million in 2024, with 47% of its sales coming from exports. The company employs around 250 people and sources milk from about 1,000 farms, with nearly 60% being organic [4]. Financial Performance - In 2024, SalzburgMilch generated sales of €350 million ($405 million), with more than 40% derived from exports [4]. - Pinzgau Milch's turnover for 2024 was €155 million, with exports constituting 47% of its sales [4]. Strategic Intent - The merger is intended to optimize synergies, strengthen regionality and product quality, and ensure long-term viability of the farming structure while retaining added value within the region [2][5]. - The deal is part of a broader trend of mergers in the European dairy industry, following recent announcements by other major players [5][6].

Core Viewpoint - Serbian dairy company Imlek is being sold by private-equity investor MidEuropa to investment firm AJFH, with the transaction pending regulatory approvals [1] Company Overview - Imlek is described as the leading dairy business in Serbia and the Balkans, operating four production facilities in Belgrade and processing 400 million liters of milk annually from over 3,500 farmers [2][3] - The company offers a variety of dairy products, including butter, yogurt, flavored milk drinks, cheese, and kefir, and owns several brands such as Moja Kravica and Mlekara Subotica [3] Transaction Details - The acquisition is led by Andrej Jovanović, the entrepreneur behind AJFH, and Imlek's CEO Bojan Radun, with plans to drive the company's growth [2][3] - The transaction is expected to close in the first quarter of the upcoming year [3] Leadership Background - Andrej Jovanović co-founded Marbo Products, now a subsidiary of PepsiCo, and has experience in the food and drinks sector [4] - Bojan Radun has been CEO of Imlek since 2018 and has a significant interest in juice producer Nectar [5] Financial Context - MidEuropa previously acquired Imlek as part of its purchase of Danube Foods Group, which reported revenues of €400 million (approximately $461 million) in 2014 [5]

Core Insights - B&G Foods, Inc. reported better-than-expected earnings for Q3 fiscal 2025 despite ongoing top-line pressures, with adjusted earnings of 15 cents per share, up 15.4% from 13 cents in the previous year [3][10] - The company experienced a 4.7% year-over-year decline in net sales to $439.3 million, primarily due to lower volumes and unfavorable foreign exchange, although improved pricing and product mix provided some offset [3][4] Financial Performance - Adjusted EBITDA remained steady at $70.4 million, with an adjusted EBITDA margin improvement from 15.3% to 16% [5] - SG&A expenses decreased by 3% year over year to $44.6 million, while as a percentage of sales, SG&A rose slightly to 10.2% [5] - The adjusted gross profit was $98.8 million, down from $102.4 million in the year-ago period, but the adjusted gross margin expanded by 30 basis points to 22.5% [4] Segment Performance - Specialty segment net sales fell 6.5% to $150.5 million, with adjusted EBITDA dropping 8.7% to $37.7 million [6] - Meals segment net sales dipped 1.4% to $110 million, while adjusted EBITDA grew 2.7% to $23.9 million [6] - Frozen & Vegetables segment saw a 13.2% drop in net sales to $77.4 million, but adjusted EBITDA surged to $4.2 million from $1.2 million [7] - Spices & Flavor Solutions segment net sales rose 2.1% to $101.4 million, although adjusted EBITDA decreased 7.4% to $26.4 million due to higher raw material costs [8] Financial Health - B&G Foods ended the quarter with cash and cash equivalents of $60.9 million, net long-term debt of $2,020.4 million, and total shareholders' equity of $470.7 million [9] Outlook - The company narrowed its fiscal 2025 outlook, projecting net sales between $1.82 billion and $1.84 billion, adjusted EBITDA of $273 million to $280 million, and adjusted earnings per share in the range of 50-58 cents [11]

Core Insights - McCormick & Company Inc. experienced a decline in adjusted gross profit margin by 120 basis points in Q3 2025 due to higher tariffs, increased commodity costs, and expenses related to capacity expansion [1][9] - The company's Comprehensive Continuous Improvement (CCI) program provided meaningful savings, leading to a 2% increase in adjusted operating income despite inflationary pressures [2][9] - McCormick reduced selling, general & administrative (SG&A) expenses by 100 basis points, primarily through employee-related cost reductions linked to the CCI program [3][9] - The company anticipates continued cost pressures through year-end, projecting flat full-year gross margins, but expects modest improvement in Q4 as savings initiatives gain traction [4][9] - McCormick's focus on cost optimization and strategic capacity investments is expected to support gradual margin recovery and long-term operational resilience [5] Financial Performance - McCormick's shares have declined by 16.1% year-to-date, compared to the industry's decline of 13.7% [6] - The forward price-to-earnings ratio for McCormick is 19.92X, which is higher than the industry average of 14.65X [7] - The Zacks Consensus Estimate for McCormick's fiscal 2025 and 2026 earnings indicates a year-over-year rise of 2.4% and 6.9%, respectively [10]

Core Insights - Medifast, Inc. reported third-quarter 2025 results with revenues exceeding estimates but a wider-than-expected loss per share, indicating a year-over-year decline in both metrics [1][11] - The company is transitioning its focus from weight loss to metabolic health, aiming to address underlying metabolic issues and tap into a larger market [1][11] Financial Performance - The company reported a quarterly loss of $0.21 per share, which was significantly worse than the Zacks Consensus Estimate of a loss of $0.01, marking a reversal from a profit of $0.10 per share in the same quarter last year [2][11] - Net revenues were $89.4 million, down 36.2% year over year, primarily due to a decrease in active earning OPTAVIA coaches, although this figure surpassed the consensus estimate of $86 million [3][11] - The average revenue per active earning OPTAVIA Coach decreased to $4,585 from $4,672, attributed to challenges in client acquisition linked to the rise of GLP-1 medications for weight loss [3][4] Operational Metrics - The number of active earning OPTAVIA coaches fell by 35% to 19,500 from 30,000 in the prior year, reflecting ongoing difficulties in client acquisition [4][11] - Gross profit was $62.2 million, down 41.2% year over year, with a gross margin of 69.5%, a decline of 590 basis points due to fixed cost leverage loss and product reformulation reserves [5][11] - Selling, general and administrative expenses (SG&A) decreased by 36% year over year to $66.2 million, driven by lower OPTAVIA coach compensation and reduced marketing costs [6][11] Margin Analysis - SG&A as a percentage of revenues increased by 20 basis points year over year to 74.1%, primarily due to fixed cost leverage loss [7][11] - The loss from operations was $4.1 million, representing a loss margin of 4.6% compared to an operating income of $2.1 million and a margin of 1.5% in the prior-year period [8][11] Financial Health - As of September 30, 2025, the company had cash, cash equivalents, and investment securities totaling $173.5 million, with no debt and total shareholders' equity of $214.7 million [9][11] Future Outlook - For the fourth quarter of 2025, Medifast expects revenues between $65 million and $80 million, with a projected loss per share ranging from $0.70 to $1.25 [12][11]

Core Insights - Kimberly-Clark Corporation (KMB) demonstrated resilient consumer demand and steady volume growth in Q3 2025, despite ongoing margin pressures, with results aligning closely with the previous year's performance under its Powering Care strategy [1] Financial Performance - Adjusted earnings per share (EPS) for Q3 2025 were $1.82, matching the prior year's figure and exceeding the Zacks Consensus Estimate of $1.45 [2] - Net sales reached $4.2 billion, consistent with the prior year, despite a 2.2% negative impact from exiting the private-label diaper business in the U.S. Organic sales increased by 2.5%, supported by a 2.4% rise in volume [3] - The adjusted gross margin was 36.8%, down 170 basis points year over year, primarily due to cost inflation and tariff-related expenses [4] - Adjusted operating profit was $683 million, remaining flat compared to the previous year, with reduced expenses offsetting gross margin challenges [4] Segment Performance - The North America segment reported net sales of $2.7 billion, a decrease of 0.8%, while organic sales grew by 2.7% driven by a 2.6% volume increase [6] - The International Personal Care segment achieved $1.4 billion in sales, up 1.9%, with organic sales growth of 2.1% [7] Financial Health - At the end of the quarter, Kimberly-Clark had cash and cash equivalents of $617 million, long-term debt of $6.47 billion, and total stockholders' equity of $1.468 billion [8] - Year-to-date cash provided by operations was $1.8 billion, with capital spending totaling $741 million and $1.4 billion returned to shareholders through dividends and buybacks [8] Future Outlook - For 2025, organic sales growth is expected to align with market trends at around 2%, with reported net sales facing headwinds from currency movements and business divestitures [11] - Adjusted operating profit is forecasted to rise at a low single-digit rate on a constant-currency basis, impacted by divestitures and unfavorable foreign exchange [12] - Adjusted EPS is anticipated to increase at a low-to-mid single-digit rate, incorporating various impacts from divestitures and higher interest expenses [13] - Management projects adjusted free cash flow of approximately $2 billion for 2025 [14]

Core Insights - McCormick & Company, Incorporated (MKC) reported third-quarter fiscal 2025 results showing volume-led growth and resilience despite a challenging cost environment, with both earnings and sales increasing year over year and surpassing the Zacks Consensus Estimate [1] Financial Performance - Adjusted earnings per share rose to 85 cents, up from 83 cents in the prior year, exceeding the Zacks Consensus Estimate of 81 cents, driven by higher operating income and disciplined cost management, although gross margin softened due to rising commodity costs and tariffs [2] - Net sales reached $1,724.9 million, a 3% increase year over year, including a 1% positive currency impact, beating the consensus mark of $1,715 million; organic sales grew 2%, supported by volume growth of over 1% and a 1% contribution from pricing [3] - Gross profit for the quarter was $645.1 million, down from $649.9 million in the previous year, with gross margin contracting 130 basis points to 37.4%; adjusted gross margin also contracted 120 basis points due to elevated input costs [4] Segment Performance - Consumer segment sales advanced 4% year over year to $973 million, with organic sales growing 3% driven by improved volume and mix; adjusted operating income rose 4% to $194 million [6] - Flavor Solutions segment sales increased 1% to $752 million, with organic sales up 1% on pricing; adjusted operating income dipped 2% to $100 million due to higher input costs and tariffs [7] Financial Health - McCormick ended the quarter with cash and cash equivalents of $94.9 million, long-term debt of $3.1 billion, and total shareholders' equity of $5.8 billion; year-to-date operating cash flow was $420.2 million, with expectations for robust cash generation in fiscal 2025 [8] Future Outlook - The company reiterated its sales growth outlook for fiscal 2025 while lowering profitability guidance due to rising commodity costs and tariffs, expecting net sales growth of 0-2% [9][10] - Adjusted EPS is now projected between $3.00 and $3.05, indicating 2-4% year-over-year growth, down from the previous expectation of $3.03 to $3.08 [11]

Industry Event - The American Dairy Association unveiled the 57th annual butter sculpture at the New York State Fair [1] - The sculpture commemorates the 125th anniversary of the Wizard of Oz [1] Production Details - The butter sculpture is made of 800 lb of butter [1] - It took 11 days to create the sculpture [1] Sustainability - The butter will be recycled and used as a renewable energy source after the fair [1]

I would really appreciate a massive tub of butter or cheese in this very moment.Thank you ...